Literature DB >> 16684530

MRI-guided gene therapy.

Xiaoming Yang1, Ergin Atalar.   

Abstract

MRI has the ability to generate high-contrast and high-resolution images, to obtain multiple diagnostic evaluations of organ function and morphology, and to provide multiple image planes with no risk of ionizing radiation. Recent efforts have focused on using MR technology to monitor gene delivery, to enhance gene transfection/transduction, and to track gene expression. This review summarizes the current status of MRI-guided gene therapy.

Mesh:

Year:  2006        PMID: 16684530     DOI: 10.1016/j.febslet.2006.04.027

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  An overview on the advances in cardiovascular interventional MR imaging.

Authors:  Olaf Saborowski; Maythem Saeed
Journal:  MAGMA       Date:  2007-05-09       Impact factor: 2.310

2.  The Use of Gene Therapy for Ablation of Atrial Fibrillation.

Authors:  Zhao Liu; J Kevin Donahue
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

Review 3.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; M H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 4.  MR fluoroscopy in vascular and cardiac interventions (review).

Authors:  Maythem Saeed; Steve W Hetts; Joey English; Mark Wilson
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-26       Impact factor: 2.357

Review 5.  Recent Advances in Functionalized Nanoparticles in Cancer Theranostics.

Authors:  Sarkar Siddique; James C L Chow
Journal:  Nanomaterials (Basel)       Date:  2022-08-17       Impact factor: 5.719

6.  Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors.

Authors:  Balaji Sitharaman; Tatiana Y Zakharian; Anita Saraf; Preeti Misra; Jared Ashcroft; Su Pan; Quynh P Pham; Antonios G Mikos; Lon J Wilson; David A Engler
Journal:  Mol Pharm       Date:  2008-05-28       Impact factor: 4.939

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.